ISRCTN26825087
Completed
未知
Irish Pharmacy Union (IPU) Pilot to Detect Hypertension and Atrial Fibrillation: to provide a health check and heart health information service to people 50 years of age and over to determine the proportion of people in that cohort with hypertension and/or atrial fibrillation.
Irish Pharmacy Union0 sites1,000 target enrollmentApril 26, 2018
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Hypertension and atrial fibrillation
- Sponsor
- Irish Pharmacy Union
- Enrollment
- 1000
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. 50 years of age and over
- •2\. No previous history of cardiovascular disease, atrial fibrillation, TIA, stroke;
- •3\. People who are receiving treatment for hypertension or diabetes will be included to see if they have atrial fibrillation.
Exclusion Criteria
- •1\.People under 50 years of age;
- •2\.People with history of cardiovascular disease, atrial fibrillation, TIA, stroke;
- •3\.People under the care of psychiatric services;
- •4\.People not able to participate in the study due to language difficulties.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Pharmacy-based interdisciplinary screening for hypertensioHypertentionDRKS00027497ABDA - Bundesvereinigung Deutscher Apothekerverbände e. V.100
Unknown
Not Applicable
POwERPACTR202001785886049niversity of Oxford100
Active, not recruiting
Phase 1
Phase I trial: Royal Infirmary Edinburgh Clinical Research Facility code: 003The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.Not ApplicableISRCTN76722400Vifor (International) Inc.90
Active, not recruiting
Not Applicable
First international trial for diagnosia nd treatment of langerhans cell histiocytosis in adults - LCH-A1angerhans cell histiocytosisMedDRA version: 9.1Level: HLTClassification code 10020118Term: HistiocytosesEUCTR2006-002392-40-ITAZ. DI RILIEVO NAZ. E DI ALTA SPECIALIZZAZIONE OSP. CIVICO E BENFRATELLI, G.DI CRISTINA E M.ASCOLI250
Completed
Phase 4
Top Institute Pharma (TIP) - research UMCU-rheumatology: *Metabolic adverse events/co-morbidity in chronic rheumatoid arthritis patients*diabetesrheumatism100184241001331710028377NL-OMON32316niversitair Medisch Centrum Utrecht300